Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeStance Health (LFST) Cash from Investing Activities (2020 - 2025)

LifeStance Health (LFST) has disclosed Cash from Investing Activities for 6 consecutive years, with -$10.9 million as the latest value for Q4 2025.

  • On a quarterly basis, Cash from Investing Activities fell 73.16% to -$10.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$36.1 million, a 67.51% decrease, with the full-year FY2025 number at -$36.1 million, down 67.51% from a year prior.
  • Cash from Investing Activities was -$10.9 million for Q4 2025 at LifeStance Health, down from -$10.3 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of -$5.1 million in Q3 2024 to a low of -$79.6 million in Q4 2021.
  • A 5-year average of -$19.4 million and a median of -$11.2 million in 2023 define the central range for Cash from Investing Activities.
  • Peak YoY movement for Cash from Investing Activities: tumbled 329.7% in 2022, then skyrocketed 81.47% in 2024.
  • LifeStance Health's Cash from Investing Activities stood at -$79.6 million in 2021, then skyrocketed by 61.92% to -$30.3 million in 2022, then surged by 62.33% to -$11.4 million in 2023, then skyrocketed by 44.8% to -$6.3 million in 2024, then crashed by 73.16% to -$10.9 million in 2025.
  • Per Business Quant, the three most recent readings for LFST's Cash from Investing Activities are -$10.9 million (Q4 2025), -$10.3 million (Q3 2025), and -$7.8 million (Q2 2025).